Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OFATUMUMAB Cause Thrombocytopenia? 354 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 354 reports of Thrombocytopenia have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.2% of all adverse event reports for OFATUMUMAB.

354
Reports of Thrombocytopenia with OFATUMUMAB
1.2%
of all OFATUMUMAB reports
13
Deaths
12
Hospitalizations

How Dangerous Is Thrombocytopenia From OFATUMUMAB?

Of the 354 reports, 13 (3.7%) resulted in death, 12 (3.4%) required hospitalization, and 3 (0.8%) were considered life-threatening.

Is Thrombocytopenia Listed in the Official Label?

Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for OFATUMUMAB.

What Other Side Effects Does OFATUMUMAB Cause?

Fatigue (5,202) Headache (4,430) Pain (3,382) Chills (3,372) Pyrexia (3,370) Influenza like illness (2,727) Nausea (1,688) Multiple sclerosis relapse (1,525) Covid-19 (1,435) Asthenia (1,393)

What Other Drugs Cause Thrombocytopenia?

DEXAMETHASONE (5,873) RITUXIMAB (4,810) CYCLOPHOSPHAMIDE (4,669) LENALIDOMIDE (4,584) CARBOPLATIN (4,483) METHOTREXATE (3,865) DOXORUBICIN (3,638) ETOPOSIDE (3,085) VINCRISTINE (2,940) OXALIPLATIN (2,886)

Which OFATUMUMAB Alternatives Have Lower Thrombocytopenia Risk?

OFATUMUMAB vs OFLOXACIN OFATUMUMAB vs OLANZAPINE OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE OFATUMUMAB vs OLAPARIB OFATUMUMAB vs OLARATUMAB

Related Pages

OFATUMUMAB Full Profile All Thrombocytopenia Reports All Drugs Causing Thrombocytopenia OFATUMUMAB Demographics